![](/img/cover-not-exists.png)
The Cost-Utility of Fidaxomicin as Compared to Current Standard Treatment in the Management of Clostridium Difficile Infections in Belgium
Lamotte, M., Vellopoulou, K., Richir, K., Smets, J., Grabe, K., Coppens, K.Volume:
16
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2013.08.1123
Date:
November, 2013
File:
PDF, 58 KB
english, 2013